These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22951172)

  • 1. The prevalence of prostate cancer in Brazil is higher in Black men than in White men: systematic review and meta-analysis.
    Romero FR; Romero AW; Almeida RM; Tambara Filho R
    Int Braz J Urol; 2012; 38(4):440-7. PubMed ID: 22951172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneous methodology of racial/ethnic classification may be responsible for the different risk assessments for prostate cancer between Black and White men in Brazil.
    Romero FR; Xavier LR; Romero AW; Almeida RM; Matias JE; Tambara Filho R
    Int Braz J Urol; 2015; 41(2):360-6. PubMed ID: 26005980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate Cancer Among Black Men in Canada.
    Albers P; Bashir S; Mookerji N; Broomfield S; Martín AM; Ghosh S; Kinnaird A
    JAMA Netw Open; 2024 Jun; 7(6):e2418475. PubMed ID: 38916889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate specific antigen levels in young adulthood predict prostate cancer risk: results from a cohort of Black and White Americans.
    Whittemore AS; Cirillo PM; Feldman D; Cohn BA
    J Urol; 2005 Sep; 174(3):872-6; discussion 876. PubMed ID: 16093978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in the prevalence of modifiable risk and protective factors for prostate cancer by race and ethnicity in the National Health and Nutrition Examination Survey.
    Defever K; Platz EA; Lopez DS; Mondul AM
    Cancer Causes Control; 2020 Sep; 31(9):851-860. PubMed ID: 32666408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testis and prostate cancer incidence in ethnic groups in South East England.
    Jack RH; Davies EA; Møller H
    Int J Androl; 2007 Aug; 30(4):215-20; discussion 220-1. PubMed ID: 17573844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Self-Reported Chronic Diseases and Health Services Utilization by Ethnic Minorities in Manaus Metropolitan Region.
    de Alencar RRFR; Galvao TF; Antonio BVR; Silva MT
    Ethn Dis; 2018; 28(1):49-54. PubMed ID: 29467566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial/ethnic differences in serum sex steroid hormone concentrations in US adolescent males.
    Lopez DS; Peskoe SB; Joshu CE; Dobs A; Feinleib M; Kanarek N; Nelson WG; Selvin E; Rohrmann S; Platz EA
    Cancer Causes Control; 2013 Apr; 24(4):817-26. PubMed ID: 23354421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of ethnicity and survival in peritoneal dialysis: a cohort study of incident patients in Brazil.
    Fernandes NM; Hoekstra T; van den Beukel TO; Tirapani L; Bastos K; Pecoits-Filho R; Qureshi AR; Dekker FW; Bastos MG; Divino-Filho JC
    Am J Kidney Dis; 2013 Jul; 62(1):89-96. PubMed ID: 23591290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Geographic Distribution of Racial Differences in Prostate Cancer Mortality.
    Fletcher SA; Marchese M; Cole AP; Mahal BA; Friedlander DF; Krimphove M; Kilbridge KL; Lipsitz SR; Nguyen PL; Choueiri TK; Kibel AS; Trinh QD
    JAMA Netw Open; 2020 Mar; 3(3):e201839. PubMed ID: 32232449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating racial differences in clinical and pathological features of prostate cancer in South African men.
    Dewar M; Kaestner L; Zikhali Q; Jehle K; Sinha S; Lazarus J
    S Afr J Surg; 2018 Jun; 56(2):54-58. PubMed ID: 30010267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating Black-White differences in prostate cancer prognosis: A systematic review and meta-analysis.
    Evans S; Metcalfe C; Ibrahim F; Persad R; Ben-Shlomo Y
    Int J Cancer; 2008 Jul; 123(2):430-435. PubMed ID: 18452170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathological Lesions and Cognitive Abilities in Black and White Older Adults in Brazil.
    Suemoto CK; Leite REP; Paes VR; Rodriguez R; Justo AFO; Naslavsky MS; Zatz M; Pasqualucci CA; Nitrini R; Ferriolli E; Jacob-Filho W; Grinberg LT
    JAMA Netw Open; 2024 Jul; 7(7):e2423377. PubMed ID: 39052291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in the Incidence of Fatal Prostate Cancer in the United States by Race.
    Kelly SP; Rosenberg PS; Anderson WF; Andreotti G; Younes N; Cleary SD; Cook MB
    Eur Urol; 2017 Feb; 71(2):195-201. PubMed ID: 27476048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal and spatial trends and determinants of aggressive prostate cancer among Black and White men with prostate cancer.
    Wang M; Chi G; Bodovski Y; Holder SL; Lengerich EJ; Wasserman E; McDonald AC
    Cancer Causes Control; 2020 Jan; 31(1):63-71. PubMed ID: 31732913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial Inequities in the Control of Hypertension and the Explanatory Role of Residential Segregation: a Decomposition Analysis in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).
    Guimarães JMN; Jackson JW; Barber S; Griep RH; da Fonseca MJM; Camelo LV; Barreto SM; Schmidt MI; Duncan BB; Cardoso LO; Pereira AC; Chor D
    J Racial Ethn Health Disparities; 2024 Apr; 11(2):1024-1032. PubMed ID: 37052798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA.
    Lediju O; Ikuemonisan J; Salami SS; Adejoro O
    J Racial Ethn Health Disparities; 2019 Apr; 6(2):401-408. PubMed ID: 30506310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partitioned prostate cancer prevalence estimates: an informative measure of the disease burden.
    Merrill RM
    J Epidemiol Community Health; 2001 Mar; 55(3):191-7. PubMed ID: 11160174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overall Survival of Black and White Men With Metastatic Castration-Resistant Prostate Cancer Treated With Docetaxel.
    Halabi S; Dutta S; Tangen CM; Rosenthal M; Petrylak DP; Thompson IM; Chi KN; Araujo JC; Logothetis C; Quinn DI; Fizazi K; Morris MJ; Eisenberger MA; George DJ; De Bono JS; Higano CS; Tannock IF; Small EJ; Kelly WK
    J Clin Oncol; 2019 Feb; 37(5):403-410. PubMed ID: 30576268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGF1 (CA)19 repeat and IGFBP3 -202 A/C genotypes and the risk of prostate cancer in Black and White men.
    Schildkraut JM; Demark-Wahnefried W; Wenham RM; Grubber J; Jeffreys AS; Grambow SC; Marks JR; Moorman PG; Hoyo C; Ali S; Walther PJ
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):403-8. PubMed ID: 15734965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.